BOSTON SCIENTIFIC CORP is 66.4x more valuable than TANDEM DIABETES CARE INC by market capitalization ($71.85 B vs $1.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TNDM | BSX |
|---|---|---|
| Market cap | $1.08 B | $71.85 B |
| US-listed rank | #2591 | #236 |
| Revenue (latest FY) | $1.01B | $20.07B |
| Net income (latest FY) | -$204.70M | - |
| Net margin | -20.2% | - |
| SEC filings | 1,234 | 1,009 |
BOSTON SCIENTIFIC CORP is 66.4x more valuable than TANDEM DIABETES CARE INC by market capitalization ($71.85 B vs $1.08 B).
In their latest fiscal years, TANDEM DIABETES CARE INC reported $1.01B in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: TANDEM DIABETES CARE INC and BOSTON SCIENTIFIC CORP, or browse the full rankings.